Delivery Order SPE2DB22D2006-SPE2DB25FV8FH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,316.77 on December 9, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine used for immunization against multiple strains of meningococcal disease. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.60 to AmerisourceBergen Drug Corp for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract, executed on July 14, 2025, with an ultimate completion date of July 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.88 to AmerisourceBergen Drug Corp for Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract was awarded on July 28, 2025, with completion targeted for July 29, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. The contract is valued at $1,007.16 with a completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,342.88 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine. This firm fixed price, non-set-aside contract is scheduled for completion by September 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,035.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Menveo A-C-Y-W Kit (2 vials), a meningococcal vaccine product. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 12, 2025, and fulfillment based in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's existing federal contract...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FV8FHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 7, 2025, for the supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal conjugate vaccine used for immunization against multiple meningococcal serogroups. This competitively awarded, non-set-aside contract has a ceiling value of $1,678.60 with a firm fixed price structure and an ultimate completion date of February 10, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables the pharmaceutical distributor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal procurement portfolio demonstrates extensive capability in delivering critical pharmaceutical commodities across multiple therapeutic domains to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 2/7/25 |